Kelly Regal

Sr. Research Investigator at Array BioPharma Inc. - Boulder, CO, US

Kelly Regal's Contact Details
HQ
303-381-6600
Location
Company
Array BioPharma Inc.
Kelly Regal's Company Details
Array BioPharma Inc. logo, Array BioPharma Inc. contact details

Array BioPharma Inc.

Boulder, CO, US • 100 - 249 Employees
Major Drugs

Array BioPharma Inc. (NASDAQ: ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics). We have locations in Boulder, CO; Cambridge, MA; and Morrisville, NC.

oncology biotechnology melanoma colorectal cancer B2B Major Drugs Pharmaceutical Preparations Pharmaceuticals
Details about Array BioPharma Inc.
Frequently Asked Questions about Kelly Regal
Kelly Regal currently works for Array BioPharma Inc.
Kelly Regal's role at Array BioPharma Inc is Sr. Research Investigator.
Kelly Regal's email address is ***@arraybiopharma.com. To view Kelly Regal's full email address, please signup to ConnectPlex.
Kelly Regal works in the Pharmaceuticals industry.
Kelly Regal's colleagues at Array BioPharma Inc. are Fredrik Marmsater, Chung-i Chang, Renae Chavira, Coralee Mannila, Kelly Mcgrew, Tony Morales, Adam Golos and others.
Kelly Regal's phone number is 303-381-6600
See more information about Kelly Regal